CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
61.29
-0.59 (-0.95%)
At close: Mar 9, 2026, 4:00 PM EDT
62.49
+1.20 (1.96%)
After-hours: Mar 9, 2026, 7:34 PM EDT
CG Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 32.49 | 257.07 | 8.27 | 88.14 | 53.61 |
| Short-Term Investments | 709.67 | 484.93 | 179.41 | 55.34 | - |
| Cash & Short-Term Investments | 742.16 | 742 | 187.67 | 143.48 | 53.61 |
| Cash Growth | 0.02% | 295.37% | 30.80% | 167.65% | - |
| Accounts Receivable | 0.69 | - | - | - | - |
| Other Receivables | - | - | 0.09 | 0.3 | 0 |
| Receivables | 0.69 | - | 0.09 | 0.3 | 0 |
| Inventory | 1.57 | - | - | - | - |
| Prepaid Expenses | 15.07 | 12.21 | 6.36 | 3.42 | 4.8 |
| Total Current Assets | 759.48 | 754.21 | 194.12 | 147.21 | 58.41 |
| Property, Plant & Equipment | 19.57 | 0.49 | 0.49 | 0.51 | 0.2 |
| Goodwill | 10.3 | - | - | - | - |
| Other Intangible Assets | 0.58 | - | - | - | - |
| Long-Term Deferred Charges | - | - | 4.67 | - | - |
| Other Long-Term Assets | 1.68 | 0.09 | 0.02 | 0.03 | 0.09 |
| Total Assets | 791.59 | 754.8 | 199.3 | 147.75 | 58.69 |
| Accounts Payable | 5.71 | 6.52 | 3.24 | 0.99 | 1 |
| Accrued Expenses | 23.12 | 14.23 | 9.68 | 5.12 | 1.89 |
| Current Portion of Long-Term Debt | - | - | - | 8.97 | 2.94 |
| Current Portion of Leases | 0.92 | 0.19 | 0.22 | 0.19 | 0.07 |
| Current Unearned Revenue | 0.29 | - | - | - | - |
| Other Current Liabilities | 0.8 | 0.44 | 1.12 | 0.17 | 0.07 |
| Total Current Liabilities | 30.84 | 21.37 | 14.25 | 15.43 | 5.98 |
| Long-Term Debt | 3 | - | - | 6.53 | 12.06 |
| Long-Term Leases | 3.11 | 0.05 | 0.24 | 0.26 | 0.05 |
| Long-Term Deferred Tax Liabilities | 0.31 | - | - | - | - |
| Other Long-Term Liabilities | 1.74 | - | 0.01 | 0.35 | 0.35 |
| Total Liabilities | 38.99 | 21.42 | 14.51 | 22.57 | 18.44 |
| Common Stock | 0.01 | 0.01 | - | - | 0 |
| Additional Paid-In Capital | 1,132 | 951.35 | 6.84 | 3.64 | 3.27 |
| Retained Earnings | -378.98 | -217.98 | -129.94 | -81.34 | -45.89 |
| Total Common Equity | 752.6 | 733.38 | -123.1 | -77.69 | -42.62 |
| Shareholders' Equity | 752.6 | 733.38 | 184.79 | 125.18 | 40.25 |
| Total Liabilities & Equity | 791.59 | 754.8 | 199.3 | 147.75 | 58.69 |
| Total Debt | 7.02 | 0.24 | 0.46 | 15.94 | 15.13 |
| Net Cash (Debt) | 735.13 | 741.76 | 187.21 | 127.54 | 38.48 |
| Net Cash Growth | -0.89% | 296.21% | 46.79% | 231.45% | - |
| Net Cash Per Share | 9.51 | 11.87 | 43.23 | 34.09 | 10.54 |
| Filing Date Shares Outstanding | 84.44 | 76.22 | 66.64 | 3.84 | 3.65 |
| Total Common Shares Outstanding | 80.69 | 76.15 | 5.22 | 3.84 | 3.65 |
| Working Capital | 728.64 | 732.84 | 179.87 | 131.78 | 52.43 |
| Book Value Per Share | 9.33 | 9.63 | -23.57 | -20.22 | -11.67 |
| Tangible Book Value | 741.73 | 733.38 | -123.1 | -77.69 | -42.62 |
| Tangible Book Value Per Share | 9.19 | 9.63 | -23.57 | -20.22 | -11.67 |
| Machinery | 6.57 | 0.36 | - | - | - |
| Leasehold Improvements | 10.5 | - | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.